November 19, 2020

Company name
Representative

Nitta Gelatin Inc.
Koichi Ogata,
Representative Director and President(Stock code: 4977; First Section of Tokyo Stock Exchange)
Contact
Norifumi Nagaoka,
Director and Executive Officer
General Manager of General Management Division
Phone Number +81-72-949-5381

Notice Concerning Absorption-Type Merger with Wholly-Owned
Subsidiary (Simplified Merger and Short-Form Merger)
Nitta Gelatin Inc. (hereinafter “Nitta Gelatin”) hereby announces that at its Board of Directors’
meeting held on November 19, 2020, Nitta Gelatin passed a resolution with respect to carrying out
an absorption-type merger with its wholly-owned subsidiary Nitta Biolab Inc. (hereinafter “NittaBiolab”) as follows, with the planned effective date of the merger being April 1, 2021.
Because the merger constitutes an absorption-type merger involving a wholly-owned subsidiary,certain disclosure matters and details are not being disclosed herein.

1. Objective of the merger
Since the establishment of Nitta Biolab, which is a wholly-owned subsidiary of Nitta Gelatin, on
September 1, 2004, it has planned, developed and sold products for consumers. Nitta Gelatin will
carry out an absorption-type merger with Nitta Biolab with the aim of increasing the efficiency ofmanagement and strengthening the planning and development of new products.

2. Outline of the merger(1) Schedule
Board resolution of the merger agreement

November 19, 2020

Execution of the merger agreement

November 19, 2020

Planned date of the merger (effective date)

April 1, 2021 (tentative)* The merger is a simplified merger pursuant to Article 796, paragraph (2) of the Companies Act fromthe perspective of Nitta Gelatin, and a short-form merger pursuant to Article 784, paragraph (1) ofthe Companies Act from the perspective of Nitta Biolab. Accordingly, neither of the two companies
will hold a shareholders meeting in order to gain approval for the merger agreement.

1(2) Method of the merger
The merger is an absorption-type merger with Nitta Gelatin as the surviving company and Nitta
Biolab to be dissolved.
(3) Details of allotment in the merger
The merger will involve neither issuance of new shares nor payment of money delivered uponmerger because Nitta Biolab is a wholly-owned subsidiary of Nitta Gelatin.
(4) Treatment of subscription rights to shares and bonds with subscription rights to shares of
the absorbed company
Not applicable.

3. Outline of the parties involved in the merger(1) Trade name(2) Head office address(3) Representative(4) Businesses(5) Capital(6) Date incorporated(7) No. of shares issued(8) Fiscal year-end

Nitta Gelatin Inc.
(Surviving company)
4-26, Sakuragawa 4-chome, Naniwa-ku,
Osaka
Representative Director and President
Koichi Ogata
Production and sales of gelatin, collagenand peptide, and products and byproducts
thereof; production and sales of adhesives,etc.; production, sales and installation ofchemical machinery; production and salesof food products and food additives; leasingof machinery and equipment; production
and sales of pharmaceuticals; production
and sales of materials for medical use;
production and sales of quasi-drugs;
production and sales of cosmetics;
production and sales of biochemical
reagents; and production and sales of finechemical materials, etc.
JPY 3,144 million
February 10, 1945
18,373,974 shares(as of September 30, 2020)
March 312Nitta Biolab Inc.
(Absorbed company)
4-26, Sakuragawa 4-chome, Naniwa-ku,
Osaka
Representative Director and President
Yoshitaka Oda
Planning, development, import, production
and sales of pharmaceuticals, quasi-drugs,
cosmetics and medical devices; planning,development, import, production and salesof daily consumer goods; planning,development, import, production and salesof foods; and advertising agency business

JPY 95 million
September 1, 2004
2,000 shares
March 31

(9) Major shareholders
and shareholding
ratio of each

IBP Co., Ltd. ·························· 19.05% Nitta Gelatin Inc.························ 100%
The Master Trust Bank of Japan, Ltd.
(Trust a/c) ································5.71%
Nitta Corporation ·······················4.57%
Sumitomo Mitsui Banking Corporation············································3.43%
MUFG Bank, Ltd. ······················3.38%
Nitta Gelatin Employees Shareholding
Association ······························2.56%
Custody Bank of Japan, Ltd.
(Trust a/c) ································2.23%
Ishizuka Corporation ···················2.13%
Hiroshi Nitta ····························2.12%
Nitta Gelatin Business Partners
Shareholding Association ·············1.89%(As of September 30, 2020)(10) Financial condition and operational results for the most recent fiscal year
Fiscal year ended
March 31, 2020 (consolidated)
March 31, 2020 (non-consolidated)
Net assets
JPY 17,461 million
JPY 71 million
Total assets
JPY 33,551 million
JPY 124 million
Net assets per share
JPY 852.71
JPY 35,822.05
Net sales
JPY 34,543 million
JPY 332 million
Operating income
JPY 1,690 million
JPY 12 million
Ordinary income
JPY 1,798 million
JPY 12 million
Net income (loss)
attributable to owners of
JPY (694) million
JPY 10 million
the parent
Net income (loss) per
JPY (37.79)
JPY 5,211.65
share

4. Status after the merger
Subsequent to the absorption-type merger, there will be no changes with respect to the trade name,head office address, title and name of the representative, businesses, capital or fiscal year-end of
Nitta Gelatin, the surviving company.

5. Impact on financial results
The merger has no material impact on Nitta Gelatin’s consolidated financial forecast for the fiscal
year ending March 31, 2021.

3

(For reference)

Full-year Consolidated Financial Forecast and the Latest Full-year Consolidated
Financial Results of the Surviving Company (announced on November 11, 2020)

Net sales
Operating income
Ordinary income
Net income (loss) attributable toowners of the parent
Net income (loss) per share

Full-year consolidated financial
forecast (FY3/2021)
JPY 31,500 million
JPY 1,300 million
JPY 1,200 million

Latest full-year consolidated
financial results (FY3/2020)
JPY 34,543 million
JPY 1,690 million
JPY 1,798 million

JPY 800 million

JPY (694) million

JPY 44.26

JPY (37.79)

4